Company will produce Trop-2 targeting antibody.



Laureate Pharma entered into a cGMP manufacturing agreement with Arius Research for its Trop-2 signal transduction antibody program.


Laureate will produce Arius’ IgG1 humanized antibody under the agreement. The product targets a novel marker that has been linked to aggressive cancers including pancreatic, colon, breast, and prostate cancer, according to Arius.








This site uses Akismet to reduce spam. Learn how your comment data is processed.